Objective The objective of this study is to investigate the association between CYP2D64, CYP3A53 and ABCB1 3435T polymorphisms and drug-related falls. Method Multivariate logistic regression was performed in an existing database in order to study the association between falls history and CYP2D64, CYP3A53, ABCB1 3435T polymorphisms in patients using fall-risk-increasing CYP2D6, CYP3A5 and P-glycoprotein (gene product of ABCB1) substrates. Results No statistically significant increased fall risk was found in 'poor metabolizers' compared to 'extensive' and 'intermediate metabolizers' using fall-risk-increasing CYP2D6 substrates (Odds ratio (OR) = 2.2; 95% confidence interval (CI) 0.2-25.0), CYP3A5 substrates (OR = 0.9; 95% CI 0.2-3.3) and P-glycoprotein substrates (OR = 2.1; 95% CI 0.2-17.2). Conclusion The hypothesis that 'poor metabolizers' have an increased fall risk was not confirmed. A larger study population is needed to confirm the potential association that was seen between CYP2D64 and ABCB1 3435T polymorphisms and drug-related falls.

, , , , , , ,
doi.org/10.1007/s11096-009-9349-1, hdl.handle.net/1765/28122
Pharmacy World and Science
Erasmus MC: University Medical Center Rotterdam

Blonk, M., van der Velde, N., van den Bemt, P., van Schaik, R., & van der Cammen, T. (2010). CYP2D6 4, CYP3A5 3 and ABCB1 3435T polymorphisms and drug-related falls in elderly people. Pharmacy World and Science, 32(1), 26–29. doi:10.1007/s11096-009-9349-1